Clinical Trials Logo

Clinical Trial Summary

Obesity is a costly multi-etiology world disease of fat storage. Morbid obesity is defines as greater than 100 pounds overweight and/or greater than 200 % of ideal body weight. Chronic underemployment, poor housing, child abuse, limited education, stress and anxiety are all associated with maternal morbid obesity. These latter conditions leave many patients in a state of economic, social and emotional poverty with need for life-long welfare support. For patients with true morbid obesity a standard surgical procedure is currently the procedure of choice especially among patients who fail standard medical intervention. The major procedures performed for morbid obesity include the Roux-en-Y gastric bypass, sleeve gastrectomy and laparoscopic band procedure. The sleeve gastrectomy is purely a restrictive procedure without malabsorptive components which involves one single staple line and can be performed laparoscopically in less than one hour. While these surgical procedures are recognized as "standard" procedures for patient who have failed medical treatment and are "covered" by most health plans, access to these procedures is limited for the medically underserved, rural, poor or underrepresented minorities since national, state and municipal health plans either provide minimal coverage or no coverage at all for surgery for morbid obesity. Reimbursement to providers offering these procedures is minimal and thus access to bariatric surgery is unlikely within a timely fashion.


Clinical Trial Description

Obesity is a costly multi-etiology world disease of fat storage. Morbid obesity is defined as greater than 100 pounds overweight and/or greater than 200 % of ideal body weight. A commonly used measure of body mass is the Body Mass Index, BMI, which is the weight in kilograms divided by the body surface area in meters squared (kg/m²). A BMI greater than or equal to 40 is defined as morbid obesity. Morbid obesity is associated with an extraordinarily high increased risk of mortality principally from cardiovascular and cerebrovascular diseases. Morbidly obese patients routinely develop early hypertension, hypercholesterolemia, and diabetes mellitus. Currently, we estimate that approximately 15% of the adult U.S. population is morbidly obese. Morbid obesity is certainly not solely a disease of the economically advantaged. In developed countries where calories are readily available and relatively inexpensive, morbid obesity is disproportionately noted in culturally and economically disadvantaged people. Most disturbing, morbid obesity is especially prevalent among lower socioeconomic women between the ages of 21-40 years, when such women are bearing and rearing children. Morbid obesity for this patient population is clearly associated with the "Metabolic Syndrome" including such documented medical conditions such as diabetes, hypertension, sleep apnea, hypercholesterolemia and ultimately early onset heart disease and chronic lung disease. In addition, chronic underemployment, poor housing, child abuse, limited education, stress and anxiety are all associated with maternal morbid obesity. These latter conditions leave many patients in a state of economic, social and emotional poverty with need for life-long welfare support. The impact on the next generation reared by these morbidly obese underserved minority patients is likely to be dire.

Currently the major treatment programs available for morbid obesity including supervised dietary programs, pre-planned meals, positive reinforcement, and even pharmacological therapies are costly and have a very low permanent success rate. For patients with true morbid obesity a standard surgical procedure is currently the procedure of choice especially among patients who fail standard medical intervention.

One of the best known international programs is Weight Watchers International. Recent studies have documented weight loss of greater to or equal to 5 kg over a 12 month period.

Weight Watchers is an international company based in the United States that offers various products and services to assist weight loss and maintenance. It was founded in 1963 and operates in about 30 countries world-wide. The Weight Watcher's philosophy is to use a science-driven approach to help participants lose weight by forming helpful habits, eating smarter, getting more exercise and providing support. Weight Watchers uses the PointPlus System. This system is a calculation based on dietary protein, carbohydrates, fat and fiber. The weekly program focuses on assisting members in creating a caloric deficit to lose weight. The Weight Watchers Program is designed to result in a weight loss of ½ to 2 pounds per week. Members of Weight Watchers will be expected to go to hourly weekly meetings for selected topic discussions and to "weigh-in". Membership in the Weight Watchers Program includes not only weekly meetings, but also access to the Weight Watchers online, access to the Weight Watchers eTools and access to the Weight Watchers mobile applications.

Weekly Meeting Process:

For the half hour prior to start-times, the participant weighs in. Weight is recorded into a computer to track the participant's progress. The topic of the week is announced (i.e. The Sleep-Weight Loss Connection). The weekly topic is discussed amongst members and the moderator (who is a Weight Watchers lifetime member) focuses on the relationship of the topic to weight loss. All are encouraged to verbally participate but it is not a requirement. The moderator rewards members who have reached certain goals. Members also discuss their progress throughout the past week. At the end of the meeting, the moderator enforces the adoption of life-style changes to incorporate the topic of the week into daily life. Members are never pressured into buying informational products, but can do so if they decide to.

The major procedures performed for morbid obesity include the Roux-en-Y gastric bypass, sleeve gastrectomy and laparoscopic band procedure. The sleeve gastrectomy is a permanent restrictive procedure without malabsorptive components which involves a single staple line and can be performed laparoscopically in less than one hour.

While these surgical procedures are recognized as "standard" procedures for patient who have failed medical treatment and are "covered" by most health plans, access to these procedures is limited for the medically underserved, rural, poor or underrepresented minorities since national, state and municipal health plans either provide minimal coverage or no coverage at all for surgery for morbid obesity. Often, these patients wait years for elective bariatric procedures. Reimbursement to providers offering these procedures is minimal and thus access to bariatric surgery is unlikely within a timely fashion.

The laparoscopic sleeve gastrectomy involves the placement of 5 trocars. First, the V-shaped liver suspension technique (V-LIST) is used to gain a broad operative view of the gastroesophageal junction[11-12] and a silicone Penrose drain is inserted into the peritoneal cavity and stapled to the pars condensa of the lesser omentum and parietal peritoneum using 2-0 Prolene (Ethicon) for liver retraction. The left lobe of liver is retracted with the V-shaped suspension technique. The greater curvature of stomach is freed beginning from 6 cm proximal to the pylorus to the angle of His with the harmonic scalpel (Ethicon). Care is taken to preserve the gastroepiploic vessels. A bougie (36-40 Fr) is placed in the stomach against the lesser curvature to guide the stapling. Gastric resection is performed with a stapler (Echelon 60, Ethicon) along a line parallel to the bougie beginning from 6 cm proximal to the pylorus and extending to the cardia. The remnant stomach is removed from the abdominal cavity by slightly enlarging the incision where the Versaport cannula has been placed. A leak check may be performed at the same time by insufflating with a gastroscope with the remnant gastric section submerged in irrigation fluid and by infusing sterile methylene blue through a nasogastric tube. The staple line may also be oversewn (3-0 Vicryl, Ethicon), only along the bleeding and leakage areas, or areas with the potential for such complications. A nasogastric decompression tube may be placed to monitor bleeding and an intraperitoneal drain placed under an anastomotic stoma.

For the purposes of this study we will consider the following to meet the criteria of populations that are underserved, rural, poor and/or underrepresented:

Medically Underserved Populations Populations that have inadequate access to, or reduced utilization of, high-quality cancer prevention, screening and early detection, treatment, and/or rehabilitation services. Included are rural, low-literacy, and low-income populations. An effort to clarify and further define "medically underserved" is currently underway at NIH.

Rural The working definition of rural, taken from the U.S. Census Bureau, is somewhat vague. "Rural" is defined as territory, populations, and housing units not classified as "urban." The Census Bureau's definition of "urban" is places of 2,500 or more persons incorporated as cities, villages, boroughs, and towns.

Poor (Low Income)

The 1998 DHHS Poverty Guidelines (also referred to as the "Federal poverty level") define a poverty threshold as an annual income of approximately $10,000 for a single individual and an annual income of approximately $20,000 for a family of 4 (Federal Register 63, #36, February 24, 1998, pp 9235-9238).

Underrepresented Minority

For NCI purposes, a person is an underrepresented minority if he or she belongs to a minority group that is underrepresented in biomedical and behavioral science careers, based on their minority group's representation in the total population. Using this definition and available data on minority representation in the health professions, science, and engineering, blacks, Hispanics, American Indian or Alaskan Native, and Pacific Islanders are classified as underrepresented minorities. Asians are not considered to be an underrepresented minority.

The bariatric surgical procedures, including the sleeve gastrectomy, performed at UCSF by the principal investigator, Dr. Stanley J. Rogers, (Chief of Minimally Invasive Surgery and Surgical Director of Bariatric Surgery) for the past 5 years, has a documented zero percent mortality, a mean 98% laparoscopic completion rate and a mean duration of hospitalization under 3 days. The cost of these procedures also is relatively inexpensive while requiring less than 2 hours of surgery time.

We propose to randomize patients to a surgical arm (sleeve gastrectomy) plus the Weight Watchers program or to the Weight Watchers program alone. We will employ extensive metrics to assess the impact of laparoscopic sleeve gastrectomy surgery plus Weight Watchers vs. Weight Watchers Program alone monitoring for 12 months the following:

Weight reduction efficacy Self-worth assessment Health care cost Economic productivity Stress and anger Intergenerational impact ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01929850
Study type Interventional
Source University of California, San Francisco
Contact
Status Withdrawn
Phase Phase 4

See also
  Status Clinical Trial Phase
Completed NCT03657927 - A Comparison of McGrath MAC Versus C-MAC Videolaryngoscopes in Morbidly Obese Patients N/A
Recruiting NCT04934826 - Comparison of the Absorption of Hydrolyzed or Intact Proteins in Morbid Obese Patients After the Roux Y Gastric Bypass N/A
Completed NCT03181347 - The Microbiology of Bariatric Surgery N/A
Completed NCT03886870 - Obesity, Lifestyle and Work Intervention N/A
Active, not recruiting NCT04433338 - The PREBA Study: Effect of Preoperative Weight Loss With a 14-day Low-calorie Diet on Surgical Procedure and Outcomes in Patients Undergoing RYGB Surgery N/A
Completed NCT03553849 - Utilization of Very Low Calorie Diet in Obese General Surgery Patients N/A
Completed NCT05854875 - Diabetes Remission After RYGBP and RYGBP With Fundus Resection N/A
Not yet recruiting NCT03203161 - Registry on Obesity Surgery in Adolescents
Not yet recruiting NCT03601273 - Bariatric Embolization Trial for the Obese Nonsurgical Phase 1
Active, not recruiting NCT02545647 - Banded Versus Non-banded Roux-en-y Gastric Bypass N/A
Recruiting NCT02129296 - Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study Phase 1/Phase 2
Active, not recruiting NCT01564732 - Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding N/A
Completed NCT02033265 - Ultrasound-Guided Axillary Brachial Plexus Block: Influence of Obesity
Not yet recruiting NCT01652105 - Randomized Trial of Preoperative Diets Before Bariatric Surgery N/A
Completed NCT01963637 - Gastric Volumetry by Gastric Tomodensitometry With Gas N/A
Terminated NCT01759550 - Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip
Completed NCT01955993 - Fentanyl Metabolism in Obese Adolescents N/A
Completed NCT01149512 - Outcomes of the Adjustable Gastric Band in a Publicly Funded Obesity Program N/A
Recruiting NCT01685177 - Single Anastomosis Duodeno-Ileal Bypass vs Standard Duodenal Switch as a Second Step After Sleeve Gastrectomy in the Super-Morbid Obese Patient N/A
Completed NCT01675713 - Lifestyleintervention for the Treatment of Severe Obesity N/A